Combined Oral Contraception and Ovarian Cancer Risk Prediction

This paper specifically examines whether women ages 25-50 who have taken oral contraceptives for at least 5 years are at a reduced risk for developing ovarian cancer over their lifetime compared to women ages 25-50 who have never used oral contraceptives. The answer to this question is particularly important in clinical practice in order to implement risk prediction and preventative counseling strategies, particularly for women with BRCA mutations, a strong family history of ovarian cancer, or personal history of breast cancer